Chemotherapy and Radiation
688 articles
Immunotherapy for Pancreatic Neuroendocrine Tumors
A clinical trial combines the immunotherapy drug pembrolizumab with lanreotide, a drug typically used to treat pancreatic neuroendocrine tumors.
Finding a Safe Dose of a New Drug for Some Types of Solid Tumors
LMB-100 is a lab-created protein that targets mesothelin. It is being tested against pancreatic cancer and other solid tumors in a clinical trial.
Combining Immunotherapy and Targeted Therapy for Pancreatic Cancer
Researchers are combining immunotherapy and targeted therapy in a clinical trial for pancreatic cancer patients on platinum-based chemotherapy.
Testing a Different Approach to Pancreatic Cancer Treatment
A drug that is epigenetic therapy, which alters how DNA behaves, is being tested in a clinical trial for pancreatic cancer.
Immunotherapy to Attack a Common Pancreatic Cancer Mutation
Researchers are testing a type of immunotherapy to attack a variant of the KRAS mutation; KRAS mutations occur in almost all pancreatic cancers.
Attacking Cancer’s Key Mechanisms to Treat Metastatic Pancreatic Cancer
A clinical trial for patients with metastatic pancreatic cancer uses the new drug SM-88 in combination with other agents, to attack the tumor metabolism.
Don’t Believe the Odds
Anne Seagren is a long-term survivor of pancreatic cancer. Chemotherapy shrank her tumor and made her eligible for a Whipple procedure.
There Is Hope for Everyone
Lee Ringuette is a 17-year pancreatic cancer survivor who changed doctors, underwent two surgeries, and grueling chemotherapy.
A Vaccine To Boost Immune Response to Pancreatic Cancer
Researchers are testing whether a vaccine can heighten the body’s immune response to pancreatic cancer after surgical removal of the tumor.
Evaluating Different Immunotherapy Combinations
A platform clinical trial evaluates immunotherapy combinations with standard of care treatment for advanced pancreatic cancer.
A New Immunotherapy Combination for Metastatic Pancreatic Cancer
Researchers are looking at a combination of two types of monoclonal antibodies to treat advanced pancreatic cancer.
The Optimist
Roxanne Waling is a long-term survivor of pancreatic cancer, and she credits her integrative oncology team for helping her through.
mRNA Vaccine Shows Promising Results
Dr. Vinod Balachandran is testing an mRNA vaccine for pancreatic cancer using the same technology as COVID vaccines.
Never Ever Ever Give Up
Lynne Holcomb turned to a clinical trial when standard treatment was not stopping her stage IV pancreatic cancer.
Another Chance at Life
Molecular profiling of long-term survivor Roy Vinke’s tumor and found a mismatch repair deficiency, which changed his treatment.